The omicron variant is substantially more contagious and reduces the effectiveness of COVID-19 vaccines, according to a new South Africa study.
Author: Karen Weintraub and Elizabeth Weise, USA TODAY
CDC recommends Pfizer COVID-19 vaccine for kids 5-11, shots expected to roll out this week
CDC experts find the benefits of Pfizer’s COVID-19 vaccine for kids 5 -11 outweigh risks. Children could begin getting shots as soon as this week.
FDA committee moves Pfizer-BioNTech COVID-19 vaccine closer to use for children ages 5-11
In children ages 5-11, the Pfizer-BioNTech vaccine was more than 90% protective against contracting symptomatic COVID-19, according to company data.
CDC endorses COVID-19 vaccine boosters for people 65 and older, high-risk patients
The CDC endorsed booster shots for millions of older and high-risk Americans, opening a major new phase in the U.S vaccination drive against COVID-19.
Pfizer-BioNTech COVID-19 vaccine becomes first to win FDA’s full approval, paving way for boosters, mandates
The FDA’s decision to fully license the Pfizer-BioNTech COVID-19 vaccine is expected to trigger more mandates and allow marketing of the shot.
Deleted gene sequences confirm coronavirus circulated before Wuhan seafood market
A new report does not answer whether the SARS-CoV-2 virus jumped directly from animals to people or was accidently leaked from a Chinese research lab.
New strains of COVID swiftly moving through the US need careful watch, scientists say
Each COVID-19 infection increases the risk of a mutation that could make it more infectious, deadlier, or different enough to make vaccines not work.
USA TODAY vaccine panel says the US has nailed the science behind the COVID vaccine. Next up: logistics and trust.
Experts are concerned some won’t trust the COVID vaccine and are wary of production problems that could delay getting it to millions of Americans.
Biden’s approach to tackling COVID-19 will be dramatically different, and quickly apparent
A Biden Administration will put science and communication first in battling COVID pandemic, health experts say.
Eli Lilly and Johnson & Johnson have paused COVID-19 vaccine trials. Why experts say that’s reassuring, not frightening.
Experts say the recent pause on COVID-19 vaccine and treatment trials aren’t unusual, but rather show scientific safety processes are working.